Skip Nav Destination
Issues
Intervirology 2002, Vol. 45, No. 4-6
Special Section
Title Page / Table of Contents
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 193–196.
https://doi.org/10.1159/000069058
Editorial
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 197–198.
https://doi.org/10.1159/000067910
Overviews
Overview of the Needs and Realities for Developing New and Improved Vaccines in the 21st Century
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 199–211.
https://doi.org/10.1159/000067911
Virus-Like Particles as a Modular System for Novel Vaccines
Subject Area:
Further Areas
Franziska Lechner; Andrea Jegerlehner; Alain C. Tissot; Patrik Maurer; Peter Sebbel; Wolfgang A. Renner; Gary T. Jennings; Martin F. Bachmann
Intervirology (2003) 45 (4-6): 212–217.
https://doi.org/10.1159/000067912
Hepatitis B Virus
Molecular Epidemiology and Immunology of Hepatitis B Virus Infection – An Update
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 218–232.
https://doi.org/10.1159/000067915
In vitro Expression of Human Hepatitis B Virus Genomes Carrying Woodchuck Hepatitis Virus Pre-S1 Sequences
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 233–236.
https://doi.org/10.1159/000067913
Immunogenic Effects of Woodchuck Hepatitis Virus Surface Antigen Vaccine in Combination with Antiviral Therapy: Breaking of Humoral and Cellular Immune Tolerance in Chronic Woodchuck Hepatitis Virus Infection
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 237–250.
https://doi.org/10.1159/000067914
Selective Expression of Immunogenic, Virus-Like Particle-Derived Antibody-Binding Epitopes
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 251–259.
https://doi.org/10.1159/000067916
Human Immunodeficiency Virus
HIV: Epidemiology and Strategies for Therapy and Vaccination
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 260–266.
https://doi.org/10.1159/000067917
Vaccine Development Using the Simian Immunodeficiency Virus Model for AIDS
Subject Area:
Further Areas
Stephen Norley; Brigitte Beer; Doris Binninger-Schinzel; Thorsten Vogel; Oliver Hohn; Erik Seibold; Dörte Radke; Corina Cosma; Reinhard Kurth
Intervirology (2003) 45 (4-6): 267–274.
https://doi.org/10.1159/000067918
Impact of Codon Usage Modification on T Cell Immunogenicity and Longevity of HIV-1 Gag-Specific DNA Vaccines
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 275–286.
https://doi.org/10.1159/000067919
Papilloma- and Polyomavirus
A Short Introduction to Papillomavirus Biology
Topic Article Package:
Topic Article Package: Cytology
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 287–289.
https://doi.org/10.1159/000067920
T Cell Response to Human Papillomavirus 16 E7 in Mice: Comparison of Cr Release Assay, Intracellular IFN-γ Production, ELISPOT and Tetramer Staining
Topic Article Package:
Topic Article Package: Cytology
Subject Area:
Further Areas
Nico Michel; Peter Öhlschläger; Wolfram Osen; Eva-Jasmin Freyschmidt; Heidrun Guthöhrlein; Andreas M. Kaufmann; Martin Müller; Lutz Gissmann
Intervirology (2003) 45 (4-6): 290–299.
https://doi.org/10.1159/000067923
Comparison of Human Papillomavirus Type 16 L1 Chimeric Virus-Like Particles versus L1/L2 Chimeric Virus-Like Particles in Tumor Prevention
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 300–307.
https://doi.org/10.1159/000067921
Generation of Recombinant Virus-Like Particles of Human and Non-Human Polyomaviruses in Yeast Saccharomyces cerevisiae
Subject Area:
Further Areas
K. Sasnauskas; A. Bulavaite; A. Hale; L. Jin; W.A. Knowles; A. Gedvilaite; A. Dargevičiūte; D. Bartkevičiūte; A. Žvirblienė; J. Staniulis; D.W.G. Brown; R. Ulrich
Intervirology (2003) 45 (4-6): 308–317.
https://doi.org/10.1159/000067922
Hantavirus
Emerging Viruses: The Case ‘Hantavirus’
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 318–327.
https://doi.org/10.1159/000067924
Review of an Inactivated Vaccine against Hantaviruses
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 328–333.
https://doi.org/10.1159/000067925
Characterization of Expression of Puumala Virus Nucleocapsid Protein in Transgenic Plants
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 334–339.
https://doi.org/10.1159/000067926
Stop Codon Insertion Restores the Particle Formation Ability of Hepatitis B Virus Core-Hantavirus Nucleocapsid Protein Fusions
Subject Area:
Further Areas
Andris Kazaks; Sylvie Lachmann; Diana Koletzki; Ivars Petrovskis; Andris Dislers; Velta Ose; Dace Skrastina; Hans R. Gelderblom; Åke Lundkvist; Helga Meisel; Galina Borisova; Detlev H. Krüger; Paul Pumpens; Rainer Ulrich
Intervirology (2003) 45 (4-6): 340–349.
https://doi.org/10.1159/000067927
Other Developments
A Malaria Vaccine Candidate Based on a Hepatitis B Virus Core Platform
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 350–361.
https://doi.org/10.1159/000067928
Cowpea Mosaic Virus: From the Presentation of Antigenic Peptides to the Display of Active Biomaterials
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 362–370.
https://doi.org/10.1159/000067929
RNA Bacteriophage Capsid-Mediated Drug Delivery and Epitope Presentation
Subject Area:
Further Areas
William L. Brown; Robert A. Mastico; Min Wu; Karen G. Heal; Chris J. Adams; James B. Murray; Jeremy C. Simpson; J. Michael Lord; Andrew W. Taylor-Robinson; Peter G. Stockley
Intervirology (2003) 45 (4-6): 371–380.
https://doi.org/10.1159/000067930
Further Section
Author Index Vol. 45, No. 4–6, 2002
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 381.
https://doi.org/10.1159/000069059
Subject Index Vol. 45, No. 4–6, 2002
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 382.
https://doi.org/10.1159/000069060
Author Index Vol. 45, 2002
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 383–384.
https://doi.org/10.1159/000069061
Subject Index Vol. 45, 2002
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 385–386.
https://doi.org/10.1159/000069062
Contents Vol. 45, 2002
Subject Area:
Further Areas
Intervirology (2003) 45 (4-6): 387–389.
https://doi.org/10.1159/000069063
